European industry puts up strong fight with regulators over implants
This article was originally published in Clinica
Executive Summary
The EU medical devices industry has built a strong case to oppose any proposals for fundamental changes to the EU Medical Devices Directive during its current five-year review. It is very worried about proposals that have been put forward by some EU competent authorities, which could have far-reaching consequences for manufacturers, particularly those concerning the reclassification of most implants from Class IIb to Class III.